- Service Name
GBS™ (Guideline-Based Segmentation)
- Industry
Healthcare, Medical Technology, Radiotherapy, Cancer Treatment
- Main Value Proposition
GBS™ empowers radiation oncology professionals to create precise, guideline-compliant contours quickly, enhancing treatment efficiency and patient outcomes.
- Description
GBS™ is an innovative solution that integrates AI-powered tools for efficient radiotherapy treatment planning. It combines Contour+, Verify, and Guide to enhance contouring precision and streamline workflows for oncology professionals.
- Key Features
AI-powered auto-contouring with Contour+; Contour assessment with Verify; Guideline training environment with Guide; Seamless integration with existing radiotherapy systems
- Use Cases
GBS™ is most valuable in scenarios requiring rapid and accurate contouring for cancer treatment, training staff in contouring practices, and improving overall clinical workflows.
- Competitive advantages
Significantly reduces contouring time by up to 95%; Standardized and consistent contours based on peer-reviewed data; Cloud-based and local compatibility with all treatment planning systems
- Strengths
The service offers high precision, efficiency, and a comprehensive approach to contouring, backed by positive testimonials from leading professionals in the field.
- Positioning
GBS™ positions itself as a cutting-edge solution that integrates AI technology with clinical expertise to transform cancer care and improve patient outcomes.
- Audience
The primary target users include radiation oncologists, medical physicists, radiation therapists, and clinical scientists who seek to enhance their contouring capabilities and treatment efficiency.
- CTA
Schedule a demo
- Tags
AI-powered radiotherapy
Contour assessment
Guideline training
Efficient treatment planning
- Tagline
Guideline-Based Segmentation Suite for Radiotherapy
- Tone of Voice
Innovative, professional, supportive
- Differentiation
GBS™ uniquely combines three essential tools—auto-contouring, contour assessment, and training—into a single suite, setting it apart from other radiotherapy solutions.
- Brand Positioning
MVision AI is identified as a leader in AI-powered radiotherapy solutions, committed to enhancing the quality of cancer treatment through innovative technology.
- Founded
2017-10-10
- Founders
Jarkko Niemelä
Mahmudul Hasan
Saad Ullah Akram